CD274 and neoplasm: The mechanisms of tumor-infiltrating DCs that hamper development of antitumor immune response include decrease in MHC class I and II levels as well as in co-stimulatory molecules (CD40, CD80, CD86), rise in co-inhibitory molecules (such as PD-L1, PD-L2, VISTA), increased tryptophan degradation by indoleamine 2,3-dioxygenase (IDO1), decreased release of IL-12, but increased secretion of IL-10 and TGF-β, among others (201).